A Drug-Drug Interaction Study of Orforglipron (LY3502970) With Quinidine in Healthy Participants
Clinical trial NCT06704763 · COMPLETED
Trial details
- NCT number
- NCT06704763
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-06
- Primary completion
- 2025-02-05
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.